Benchmark (LON:BMK) Trading Down 14.2% - What's Next?

Key Points

• Benchmark Holdings plc experienced a significant drop of 14.2% in stock price, trading as low as GBX 18 ($0.24) before recovering to GBX 19.92 ($0.27).
• The company reported a quarterly earnings loss of GBX (1.77) (($0.02)) per share, alongside a negative net margin of 43.67% and a negative return on equity of 16.05%.
• Analysts predict that Benchmark will post an EPS of 0.9566873 for the current year, indicating challenges in potential profitability moving forward.

Benchmark Holdings plc (LON:BMK - Get Free Report) traded down 14.2% during trading on Friday . The stock traded as low as GBX 18 ($0.24) and last traded at GBX 19.92 ($0.27). 205,892 shares changed hands during mid-day trading, a decline of 33% from the average session volume of 306,948 shares. The stock had previously closed at GBX 23.20 ($0.31).

Benchmark Stock Down 6.9%

The firm has a fifty day simple moving average of GBX 23.98 and a 200-day simple moving average of GBX 24.57. The firm has a market cap of £160.11 million, a price-to-earnings ratio of -4.05, a P/E/G ratio of -19.62 and a beta of 0.69. The company has a debt-to-equity ratio of 33.02, a quick ratio of 1.41 and a current ratio of 1.73.

Benchmark (LON:BMK - Get Free Report) last posted its quarterly earnings results on Thursday, June 12th. The company reported GBX (1.77) (($0.02)) EPS for the quarter. Benchmark had a negative net margin of 43.67% and a negative return on equity of 16.05%. As a group, sell-side analysts expect that Benchmark Holdings plc will post 0.9566873 EPS for the current year.

Benchmark Company Profile

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.We bring together biology and technology to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.